Header Image

Regulated clinical AI: reshaping access to mental healthcare

Healthcare Partnership Network South, 16-17 October 2025

The need for mental health services has increased dramatically in the last decade, but with a lack of staff and resources, the NHS is struggling to keep up with demand.

At HPN Mental Health Dr. Ross Harper, CEO and Founder of Limbic, delivered an inspiring keynote surrounding the possibilities of clinical AI, and how Limbic’s AI solutions are reshaping mental healthcare.

During the session, Ross shared compelling evidence from over 460,000 NHS patient assessments, demonstrating how regulated clinical AI is transforming mental healthcare access whilst still maintaining rigorous safety standards.

Here are some of the key takeaways…

Mental healthcare needs scalable solutions

Mental healthcare is facing a global crisis. While there are currently 1.6 billion people in the world with a diagnosable mental health condition, there are only 2.8 million licensed professionals available to treat them.

As Ross explained, ‘There are not enough trained mental health professionals alive on the planet to serve astronomical disorder prevalence.’

He continued, ‘Recruiting our way out of this problem is a structural impossibility. The pipeline of clinicians unfortunately is just not there.’

With such a vast and growing supply-demand gap, healthcare professionals need to find new ways to support those in distress and ease the workload of those already specialising in mental healthcare.

Enter clinical AI: a new type of workforce

Clinical AI has a huge opportunity to transform mental health services – for the better.

Rather than replacing therapists and mental health practitioners, clinical AI can act as a support tool to help tackle lower-level, administrative tasks, and enable staff to focus on delivering top quality care instead of drowning in endless paperwork.

This is where solutions like Limbic can really make a difference. As founder Ross explained:

‘At Limbic, we believe the only true path to scale in quality mental healthcare is the creation of a new workforce of clinical AI agents, which have been specially trained to operate as the lower tier in the staffing pyramid, overseen by trained clinicians and amplifying the capabilities of the existing clinician supply.’

Limbic’s end-to-end AI system was specially designed for mental healthcare and was trained on specific clinical data. The system integrates seamlessly into existing referral and care pathways, starting with intake and triage, then supporting clinicians with assessments, and finally providing ongoing, empathetic care through a generative AI companion.

Clinical AI at scale: deployment, regulation and responsibility

While AI use is becoming more common in healthcare, widespread adoption still faces resistance from both patients and staff. Trust remains a major barrier, especially when it comes to patient care. Fortunately, Limbic is already making progress. As the largest deployment of patient-facing generative AI in healthcare, Limbic is already integrated across 45% of NHS regions, supporting over 460,000 patients in routine mental health treatments.

With the rise of digital health tools in the last few years, it’s easy to mistake clinical AI for another form of wellness app. But as Ross explained, they’re very different:

‘If you want to be clinical AI and not wellness AI, you need to have a deep clinical evidence base demonstrating the impact of every claim you wish to make.’

Unlike wellness apps, Limbic’s AI tool is a fully integrated, regulated clinical solution, and has even been classified as a Class II medical device. But regulation alone isn’t enough. What sets Limbic apart is its foundation in rigorous clinical evidence, including peer-reviewed studies involving over 130,000 patients.

When it comes to vulnerable populations, clinical AI needs to be held to the highest standards of safety. As Ross pointed out, ‘There are just too many risks associated with dealing with this vulnerable patient population and not investing the time it takes to prove safety, validation and a clinical evidence base.’ He continued, ‘It is not a nice-to-have. It is not optional. This is a patient safety issue, and it must be taken seriously.’

Enhancing access, equity, and outcomes

Towards the end of the session, Ross talked about the impact Limbic has already had across the NHS.

Through its regulated, evidence-based AI platform, Limbic has driven measurable improvements, including:

  • Improved access: 15% increase in self-referrals
  • Enhanced inclusivity: Significant uplift in access for minority groups (e.g., +179% for non-binary individuals)
  • Better outcomes:
    • Higher recovery rates
    • Reduced dropout
    • Increased session attendance
    • Lower cost per recovery

They have also helped the NHS:

  • Save 5,500 years of patient wait time due to increased capacity
  • Aid 25,000 extra patients in recovery

When speaking about the results, Ross mused that clinicians shouldn’t be thinking about if they should implement clinical AI, but when:

‘I think it becomes a moral imperative when you see these sorts of results to figure out a way to safely and responsibly deploy regulated clinical AI solutions in mental healthcare. Because if we don’t, we are stuck with the status quo. I think at the end of the day, it becomes an ethical decision as to which way we would like to lean.’

He continued:

‘I encourage everybody to just ask themselves what could the world look like when Healthcare is abundant? How could things look different in a world where the highest quality mental Healthcare is available to everyone everywhere through a marriage of expert human clinicians and scalable clinical AI? It’s a world that I would like to live in.’

Join our future discussions

A big thank you to Ross Harper for his valuable insights into what clinical AI is, and how solutions like Limbic can help improve outcomes and expand access for underserved populations.

If you want to find out more about Limbic, visit https://limbic.ai/ or contact Limbic’s Client Director, Syed Abrar, at syed@limbic.ai.

If you want to take part in future discussions, register your interest to join us at HPN South on 16-17 October!